(Q35683518)

9 August 2017

1 reference

17 June 2019

Male breast carcinoma: increased awareness needed (English)

1 reference

9 August 2017

1 reference

17 June 2019

1 reference

6

Valerie Speirs

0 references

Andrew M. Hanby

5

object named as

Andrew M Hanby

1 reference

9 August 2017

Jonathan White

1

1 reference

9 August 2017

Olive Kearins

2

1 reference

9 August 2017

David Dodwell

3

1 reference

9 August 2017

Kieran Horgan

4

1 reference

9 August 2017

29 September 2011

4 references

9 August 2017

13 March 2019

3 April 2019

17 June 2019

Breast Cancer Research

4 references

9 August 2017

13 March 2019

3 April 2019

17 June 2019

13

1 reference

9 August 2017

5

1 reference

9 August 2017

219

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2930

9 August 2017

0 references

cites work

Problems (and solutions) in the study of male breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Endocrine therapy for male breast cancer: rates of toxicity and adherence

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Environmental oestrogens and breast cancer: evidence for combined involvement of dietary, household and cosmetic xenoestrogens.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Multidisciplinary meeting on male breast cancer: summary and research recommendations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Lifestyle as risk factor for cancer: Evidence from human studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

New mechanisms for PRLr action in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Prospective evaluation of risk factors for male breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Male breast cancer: is the scenario changing

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Male breast cancer: a review of clinical management

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Epidemiology of male breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Breast carcinoma in men: a population-based study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Carcinoma of the male breast: a review of adjuvant therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

The role of prolactin and growth hormone in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Conditions of the male breast: Gynaecomastia and male breast cancer (Review).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Fulvestrant for advanced male breast cancer patients: a case series.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Aromatase inhibition in male breast cancer patients: biological and clinical implications

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Fulvestrant in advanced male breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Prolactin receptor expression in gynaecomastia and male breast carcinoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Aromatase inhibitors and male breast cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Adjuvant systemic therapy for male breast carcinoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Steroid hormone receptor expression in male breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Male breast cancer: is the incidence increasing?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Complete remission obtained with letrozole in a man with metastatic breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

25 September 2018

Breast cancer in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

25 September 2018

Male breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Efficacy of anastrozole in male breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Estrogen suppression in males: metabolic effects

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262194

Linkage to BRCA2 region in hereditary male breast cancer

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2930

Fulvestrant in Advanced Male Breast Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2930

Leuprolide Acetate Plus Aromatase Inhibition for Male Breast Cancer

21 January 2018

1 reference

12 December 2020

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

1 reference

12 December 2020

Hormonal therapy for metastatic male breast cancer

1 reference

12 December 2020

Role of adjuvant chemotherapy in male breast cancer

1 reference

12 December 2020

Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects

1 reference

12 December 2020

Adjuvant chemotherapy in males with cancer of the breast

1 reference

12 December 2020

The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalec tomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids); an analysis of 42 patients

1 reference

12 December 2020

Sentinel node biopsy in male breast cancer

1 reference

12 December 2020

Tamoxifen in the treatment of male breast carcinoma

1 reference

12 December 2020

Carcinoma of the male breast

1 reference

12 December 2020

The rising incidence of male breast cancer

1 reference

12 December 2020

The experiences of men with breast cancer in the United Kingdom

1 reference

12 December 2020

Highly specific sites of prolactin binding in benign and malignant breast tissue

1 reference

12 December 2020

Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study

1 reference

12 December 2020

EFFECT OF ORCHIDECTOMY ON SKELETAL METASTASES FROM CANCER OF THE MALE BREAST

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2930

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference